Cloud-clone
SKU:RPJ847Hu01
Recombinant Retinoschisin (RS)
Recombinant Retinoschisin (RS)
Couldn't load pickup availability
Prokaryotic expression
Product No.
RPJ847Hu01
Organism Species
Homo sapiens (Human).
Source
Prokaryotic expression
Host
E.coli
Endotoxin Level
<1.0EU per 1µg (determined by the LAL method)
Subcellular Location
Secreted
Predicted Molecular Mass
53.0kDa
Accurate Molecular Mass
53kDa(Analysis of differences refer to the manual)
Residues & Tags
Ser24~Ala224 with N-terminal His and GST Tag
Buffer Formulation
20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
Traits
Freeze-dried powder
Purity
> 95%
Isoelectric Point
5.5
Applications
Positive Control; Immunogen; SDS-PAGE; WB.
If bio-activity of the protein is needed, please check active protein.
UOM
10µg 50µg 200µg 1mg 5mg
SEQUENCE
USAGE
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
STORAGE
Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Hum Gene Ther | Dextran and protamine-based solid lipid nanoparticles as potential vectors for the treatment of X-linked juvenile retinoschisis. PubMed: 22295905 |
| IEEE Transactions on Magnetics | Influence of Iron Oxide Nanoparticles on Innate and Genetically Modified Secretion Profiles of Mesenchymal Stem Cells Scholarsportal: Source |
| International Journal of Pharmaceutics | A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases Pubmed:24576595 |
| 22 | Structural recovery of the retina in a retinoschisin-deficient mouse after gene replacement therapy by solid lipid nanoparticles Pubmed:26986855 |
| UBC Library | Cell based therapeutics for retinal degenerations cIRcle:1.0303136 |
| Molecular Vision | An ex vivo gene therapy approach in X-linked retinoschisis pubmed:27390514 |
| Catalog No. | Related products for research use of Homo sapiens (Human) Organism species | Applications (RESEARCH USE ONLY!) |
| RPJ847Hu01 | Recombinant Retinoschisin (RS) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAJ847Hu01 | Polyclonal Antibody to Retinoschisin (RS) | WB |
| MAJ847Hu21 | Monoclonal Antibody to Retinoschisin (RS) | WB; IHC; ICC; IP. |
| SEJ847Hu | ELISA Kit for Retinoschisin (RS) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMJ847Hu | Magnetic Luminex Assay Kit for Retinoschisin (RS) ,etc. | Magnetic Luminex Assay for Antigen Detection. |
